Gender Differences in the Diagnosis of Dyslipidemia: ESCARVAL-GENERO

Cristina Soriano-Maldonado, Adriana Lopez-Pineda, Domingo Orozco-Beltran, Jose A. Quesada, Jose L. Alfonso-Sanchez, Vicente Pallarés-Carratalá, Jorge Navarro-Perez, Vicente F. Gil-Guillen, Jose M. Martin-Moreno and Concepción Carratala-Munuera
Additional contact information
Cristina Soriano-Maldonado: Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
Adriana Lopez-Pineda: Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
Domingo Orozco-Beltran: Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
Jose A. Quesada: Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
Jose L. Alfonso-Sanchez: Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain
Vicente Pallarés-Carratalá: Health Surveillance Unit, Castellon Mutual Insurance Union, 12004 Castellon, Spain
Jorge Navarro-Perez: Biomedical Research Institute INCLIVA, Hospital Clinico Universitario de Valencia, University of Valencia, 46010 Valencia, Spain
Vicente F. Gil-Guillen: Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain
Jose M. Martin-Moreno: Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain
Concepción Carratala-Munuera: Clinical Medicine Department, Miguel Hernandez University, 03550 San Juan de Alicante, Spain

IJERPH, 2021, vol. 18, issue 23, 1-14

Abstract: Evidence shows that objectives for detecting and controlling dyslipidemia are not being effectively met, and outcomes differ between men and women. This study aimed to assess gender-related differences in diagnostic inertia around dyslipidemia. This ambispective, epidemiological, cohort registry study included adults who presented to public primary health care centers in a Spanish region from 2008 to 2012, with dyslipidemia and without cardiovascular disease. Diagnostic inertia was defined as the registry of abnormal diagnostic parameters—but no diagnosis—on the person’s health record in a window of six months from inclusion. A total of 58,970 patients were included (53.7% women) with a mean age of 58.4 years in women and 57.9 years in men. The 6358 (20.1%) women and 4312 (15.8%) men presenting diagnostic inertia had a similar profile, although in women the magnitude of the association with younger age was larger. Hypertension showed a larger association with diagnostic inertia in women than in men (prevalence ratio 1.81 vs. 1.56). The overall prevalence of diagnostic inertia in dyslipidemia is high, especially in women. Both men and women have a higher risk of cardiovascular morbidity and mortality.

Keywords: diagnostic inertia; gender differences; dyslipidemia; primary health care (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/23/12419/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/23/12419/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:23:p:12419-:d:688090

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().